2. KHWAJA FAREED UNIVERSITY OF ENGINEERING &
INFORMATION TECHNOLOGY
Presenter: HUDA MAZHAR
{CHEM201107027}
{BS-BIOT-5A}
Instructor: Dr. MUTHAR QAISARNI
SEMINAR-I
4. Biotechnology:
Biotech is a field of technology that implements biomolecular
and cellular processes in the creation of health care, food and
fuel product.
Primary sectors of Biotech:
• Biotech in Medicine
• Biotech in Industry
• Biotech in Agriculture
6. Artificial meat
As we know that globally the meat industry is a very big
reason for methane emission, which is directly impact to our
climate.
So, the advances in biotechnology is going to help us
create this artificial meat.
It started earlier when a biotechnology was used to create
artificial body parts.
For example:
Skin Graft, where the growing skin cells created in the
laboratory and these growing skin cells where drafted on the burn
victium.
8. Agricultural BioTechnology
Due to research in Agricultural biotechnology it is
going to be possible that the new crops will be
created they will be more rich in nutrients and they
will be cost less to the enivornment when growing
them.
It means the seeds can be created they will take
less water which will directly impact to our
enivornment
9. For example
Caffeine free coffee beans
As we know, Decaffeination is very costly
So, Biotechnology helping scientists to create the coffee bean
which does not have the caffeine when the seeds was planted
11. Personalized
Medicines
Personalized
medicine is
growing as a result
of the reduced
time and costs
First genome
sequencing project
that began in 1990
took about 13
years and $2.7
billions to
complete.
Today, you can
buy quick at home
genome sequence
test for around
$299.
12. Rapid Medicine
and Treatments:
With Biotechnology,
medical professionals
can analyze genetics
to identify medical
risks in patients
By basing medical
innovation on
genetics sequencing,
doctors develop
unique, tailor hand-
maded solution.
14. Biotech Costs:
Biotech research is costly and often takes severals
years. For instance, new drugs cost around $1 billion on
average to develop.
Firms must invest heavily in research, development,
and regulatory approval before bringing a drug to
Market.
Biotech firms will continue to receive funding, but
pricing will always be a pressing concern as firms
balance profit and loss.
15. Regulatory Concern:
• There are numerous regulation that apply to the
biotech industry.
• While some restrictions were relaxed for COVID-19
research to reduce the complaince burden,
biotech-friendly exceptions are unlikely to continue
in the future.
• 91% of pharmaceutical firms think additional U.S.
regulations will be implemented beyond 2021.
16. Talent Shortage:
• The biotech industry must hire experts at the top of their
fields, and as the coronavirus pandemic continues, the
pressure of new therapies and vaccines escalates.
• But finding top talent is an onging challenge for biotech
companies.
• As demand for biotech expands, production lead times
have increased to 16 months and most life science
companies are already at capacity with research
projects.
• Talent shortage has led to companies outsourcing work.
• In additional to relying on in-house talent meet to
demand.
17. Inadequate Technology:
• Top priorities for biotech companies including,
finding way to increase automation, data
accessability and speed.
• Technological inadequacy presents a
complex hurdle when developing biologically
effective solutions to pressing problems.
• As the biotech field grows, some challenges
such as financing and regulation could be
reduced and normalized
18. Final Thoughts:
• Biotechnology advancement is paramount if we hope
to affect global change across the food, health,
industry and agriculture sectors.
• As the COVID-19 pandemic has highlighted, the need
for rapid response is curcial to combat disease, now
more than ever.
• Despite challenges, biotechnology continues to move
forward.
• Biotech trends and challenges present an excellent
investment opportunity.